ABSTRACT
OBJECTIVE: This study was conducted to determine whether routine gynecologic screening is obtained for women admitted to a medical intensive care unit in a large tertiary medical center and whether this history is used to document and update screening for these patients. METHODS: A retrospective chart review of 65 women admitted to the medical intensive care units of Harper Hospital or Detroit Receiving Hospital of the Detroit Medical Center over a period of one month. RESULTS: None of the patients eligible for cervical cytology and pelvic examination had these issues addressed in the intake history or had any of the reviewed examinations done or planned for after discharge from intensive care. CONCLUSIONS: Admission to intensive care is an opportunity to assess and update routine gynecologic health screening. This important function is not routinely addressed in the medical records of women admitted to intensive care.
ABSTRACT
We examined the effect of peptone yeast extract glucose broth (PYG), RPMI 1640 and Antibiotic Medium 3 (M3) on the in vitro susceptibility of clinical isolates (n = 200) of Aspergillus fumigatusto amphotericin B (AMB), itraconazole (ITZ) and voriconazole (VCZ). The MICs (mug/mL) of various antifungal agents (geometric mean plus/minus standard deviation) obtained in PYG, RPMI 1640 and M3, respectively, were as follows; AMB: 1.64 plus/minus 0.92, 0.42 plus/minus 0.21, 0.33 plus/minus 0.16; ITZ: 0.44 plus/minus 0.54, 0.40 plus/minus 0.65, 0.17 plus or minus 0.32; VCZ: 0.70 plus/minus 0.58, 0.29 plus/minus 0.22, 0.36 plus/minus 0.21. Pairwise comparisons of the MICs of AMB, ITZ and VCZ obtained in PYG, RPMI 1640 and M3 showed no significant differences except for AMB in PYG broth compared to those obtained in RPMI 1640 and M3 (p